Ilunocitinib
Ilunocitinib is an orally bioavailable, non-selective JAK inhibitor used in research for canine atopic dermatitis. It is employed in both in vitro and in vivo studies to investigate JAK/STAT pathway inhibition for controlling pruritus and skin inflammation associated with the condition.
Product Specifications
CAS Number
1187594-14-4
Product Name Alternative
Ilunocitinib, LY3411067, LY-3411067
Field of Research
Cardiovascular Research, Epigenetics & Chromatin, Signal Transduction, Stem Cell & Developmental Biology
Purity
99.88% (May vary between batches)
Solubility
DMSO:200 mg/mL (521.61 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (13.04 mM)
Smiles
N#CCC1 (N2N=CC (=C2) C=3N=CN=C4NC=CC43) CN (C1) S (=O) (=O) C5CC5
Molecular Formula
C17H17N7O2S
Molecular Weight
383.43
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![5,5-Dimethyl-2-[[ (phenylacetyl) amino]methyl]-4-thiazolidinecarboxylic Acid-d5 (Mixture of Diastereomers)](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
437104-01 1 mg
5,5-Dimethyl-2-[[ (phenylacetyl) amino]methyl]-4-thiazolidinecarboxylic Acid-d5 (Mixture of Diastereomers)
Sign In for Pricing
View Details